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Abstract
Background: Cytomegalovirus (CMV) infection has been associated with accelerated transplant vasculopathy.
In this study, we assessed the effects of acute rat CMV (RCMV) infection on vessel remodeling in transplant
vasculopathy, focusing on allograft morphology, inflammation and contribution of adventitial cells to intimal
hyperplasia.
Methods: Infrarenal aorta was locally infected with RCMV and transplanted from female F344 rats to male Lewis
rats. Graft samples were collected 2 and 8 weeks after transplantation and analyzed for intimal hyperplasia,
collagen degradation and inflammation. Transplantation of aorta followed by transplantation of RCMV infected and
labeled isogenic adventitia were performed to study migration of adventitial cells towards the intima.
Results: Intimal hyperplasia was increased threefold in infected allografts. RCMV induced apoptosis in the media,
expression of matrix metalloproteinase 2, and decreased collagen deposits. Macrophage infiltration was increased
in the infected allografts and resulted in increased production of MCP-1. RCMV-infected macrophages were
observed in the adventitia and intima. Cells derived from infected adventitia migrated towards the intima of the
allograft.
Conclusions: RCMV enhances infiltration of macrophages to the allografts, and thereby increases MCP-1
production and inflammation, followed by recruitment of adventitial cells to the intima and accelerated intimal
hyperplasia.
Background
Cytomegalovirus (CMV) is a well-known risk factor for
late allograft dysfunction and is also associated with
atherosclerosis and restenosis after angioplasty [1-6].
The major cause of late organ dysfunction after trans-
plantation is accelerated transplant vasculopathy (TV),
characterized by diffuse concentric intimal proliferation
that results in vessel occlusion.
In the early phase of TV, injured vessels contain predo-
minantly macrophages and a few subendothelial lympho-
cytes (T, B, and natural killer cells); late vascular lesions
are associated with a thickened intima containing cells of
smooth muscle cell (SMC) phenotype interspersed with
macrophages [7]. Intimal lesions are thought to be popu-
lated by dedifferentiated SMCs or vascular progenitor
cells, either circulating or resident in the vessel wall, e.g.
in the adventitia [8]. Furthermore, evidence has recently
emerged suggesting that a vascular adventitia is activated
in a variety of vascular diseases and plays an important
role in the progression of vascular inflammation [9,10].
The number of progenitor cells contributing to vascular
remodeling is thought to increase with the inflammatory
response and their migration to sites of vascular injury is
mediated by factors such as monocyte chemoattractant
protein 1 (MCP-1) [11].
Clinical data and animal studies suggest that CMV
contributes to the development of TV [12]. CMV infec-
tion of macrophages and endothelial cells affects cellular
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ease. For example, CMV antigens activate the immune
system [13] and hence may drive an inflammatory pro-
cess in the arterial wall [14-17]. It is hypothesized that a
local injury (e.g., allospecific injury or balloon angio-
plasty) can reactivate latent CMV in cells in the vessel
wall or in cells recruited to the site of injury [2,18-20].
The virus then initiates an acute infection and inflam-
mation, which may affect the migration and proliferation
of vascular cells. In vitro, human CMV (HCMV) infec-
tion mediates vascular SMC migration that is dependent
on the expression of the virally encoded chemokine
receptor homologue US28 [21]. Deletion of the US28
rat homolgue R33 reduces the capacity of CMV to
accelerate chronic rejection and TV in a rat model [22].
The mechanisms of HCMV-associated TV are difficult
to determine because of its multifactorial etiology.
Moreover, HCMV is ubiquitous and infects multiple cell
types, including SMCs, endothelial cells, macrophages,
and fibroblasts, and a primary infection is followed by
lifelong latency, which makes it difficult to establish a
specific temporal relationship between infection and TV
[5]. Therefore, animal models are ideal for studying the
association between CMV and TV.
The rat cytomegalovirus (RCMV) model has been use-
ful to study mechanisms of CMV-related diseases,
including the effect of the virus on TV [5,22-27]. In
immunocompromised rats, RCMV causes a widespread
infection of most tissues and various cell types, includ-
ing endothelial cells, epithelial cells, macrophages, poly-
morphonuclear cells, and fibroblasts [28]. However, the
effects of CMV infection on TV in rats and mice have
so far only been studied after systemic infection
[5,23-25,29-32].
To investigate the impact of a local CMV infection on
cellular activation and vascular graft morphology in TV,
we used a rat model in which the aorta or adventitia
were locally infected with RCMV ex vivo after collection
from the donor rat and before transplantation into the
recipient rat. This model aims to mimic the effects of a
severe systemic infection on the allograft and gives
insight into which cells in the allograft become infected,
and enable investigation of the cellular immune
response against the virus and its impact on vascular
remodelling.
Methods
Ethics statement
All animal procedures were approved by ethical com-
mittees of Stockholm North Ethical Committee and per-
formed in accordance with institutional guidelines and
c o n f o r m e dt ot h eG u i d ef o rt h eC a r ea n dU s eo f
Laboratory Animals at Karolinska Institute, Stockholm,
Sweden.
RCMV propagation
RC 127 (Maastricht strain, 2.1 × 10
6 pfu/ml; multiplicity
of infection, 3.5 × 10
-2) was originally isolated from wild
rats [33]. RCMV was propagated by infecting fibroblasts
prepared from 17-day-old DA rat embryos. The super-
natant was used for in vivo infection. Fibroblasts were
cultured in flasks containing modified Eagle’s minimum
essential medium (Flow Laboratories) supplemented
with 200 mmol/l L-glutamine (Northumbria Biologicals),
antibiotic solution (10,000 IU/ml penicillin and 1000/ig/
ml streptomycin) (Gibco), and 10% FCS (Sera-Lab) at
37°C in a 5% CO2 incubator. At confluency, the cells
were infected with RCMV according to standard viral
culture techniques [34] and maintained in culture med-
ium (as above) supplemented with 2% FCS (Sera-Lab).
After 5 to 7 days, when a cytopathic effect was observed
in at least 95% of the cells, the cells were detached from
the bottom of the flask by tapping and thereafter centri-
fuged at 1200 rpm for 5 min. The supernatant contain-
ing free RCMV was collected and immediately stored at
-70°C. The virus was a gift from Prof. Cathrien A. Brug-
geman’s laboratory.
Animal transplant models of locally infected with RCMV
aorta and adventitia and study design
Inbred male (150-170 g) Lewis rats (LEW.RT1 strain)
and female Fisher rats (F344.RT1v1 strain) were used.
Rats used for aorta transplantation study (n = 96)
were divided into two groups: allograft (F344 to LEW)
and isograft (LEW to LEW). The allograft group was
divided into two experimental groups (n = 12 rats each):
(1) RCMV-infected allografts collected after 2 weeks
(6 grafts); (2) RCMV-infected allografts collected after
8 weeks (6 grafts); and two control groups (n = 12 rats
each), (3) uninfected allografts collected after 2 weeks
(6 grafts), and (4) uninfected allografts collected after
8 weeks (6 grafts). Uninfected and infected isogenic
grafts, isografts, (n = 12 rats in each group) were used
as controls and were included to certify that there was
no intimal hyperplasia in the isografts as was previously
reported [27,31,35]. Transplantations of the infrarenal
rat aorta: allograft (F344/LEW rats) and isograft (LEW/
LEW rats) were performed as described [36]. A part of
the infrarenal aorta was taken from the donor, incubated
for 20 min with 2.1 × 10
6 pfu RCMV (tissue culture-
derived virus diluted in 1 ml of PBS), and transplanted
into recipient rats. Allograft and isograft samples were
collected 2 and 8 weeks post transplantation.
Thirty-six rats were used for adventitia transplanta-
tion. 12 rats (F344) served as donors of aorta, 12 rats of
LEW strain served as donors of adventitia, and 12 rats
of LEW strain served as recipients of both aorta and
adventitia. Four weeks after aortic abdominal allograft
transplantation (F344 to LEW), isogenic adventitial cells
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leak to adjacent cells (Molecular Probes, Carlsbad, CA),
were transplanted to the allograft by cuffing labeled
adventitia around the previously transplanted allograft.
Allograft samples were collected 2 weeks post adventitia
transplantation and studied using confocal microscopy
for the migration of adventitial cells to the intima
in vivo.
Histologic and morphometric analyses of the allografts
Transplanted aortas were collected, rinsed with 0.9%
sodium chloride, fixed in 3% buffered formaldehyde for
4 h, and stored at 4°C in PBS with 0.02% sodium azide.
Thereafter, paraffin blocks were made and allografts
were cut to obtain transverse sections at 5 μm. The sec-
tions were stained with hematoxylin and examined with
a Leica light microscope. Intima and media cross-
sectional areas were measured with LeicaQWin soft-
ware. The analysis was performed in a blinded approach
by two observers who were unaware of coding.
Immunohistochemistry of cross sections of the allografts
The following primary antibodies were used for immuno-
histochemistry: mouse anti-human SM a-actin, which is
known to stain rat SM a-actin [37] (Dako), mouse anti-
rat CD45 (BD Pharmingen), mouse anti-rat CD68 (Sero-
tec), mouse anti-rat CD3 (GeneTex), mouse anti-rat
caspase 3 (Neomarkers), mouse monoclonal antibodies
against MMP-2 and MMP-9 (Abcam), mouse anti-rat
MAb8 against RCMV early/late antigen (R44-encoded
protein, gift from C. Bruggeman), and mouse anti-MCP-
1 (Biolegend). Briefly, 5-μm paraffin sections were depar-
affinized, hydrated, and digested with pepsin. The
sections were then subjected to antigen retrieval in citrate
buffer followed by peroxidase (Innovex Sciences), avidin,
and biotin (Dako) and Fc receptor blockage (Innovex
Sciences). Sections were incubated with monoclonal anti-
bodies, and the signal was visualized with a horseradish
peroxidase detection system (BioGenex) using diamino-
benzidine (Innovex Sciences) as the chromogen. For dou-
ble immunohistochemistry, the signal was detected with
Vector alkaline phosphatase using BCIP/NBT as
substrate. After counterstaining with hematoxylin
(Sigma-Aldrich), specimens were mounted in permanent
mounting medium (Histolab).
Masson’s trichrome staining of cross sections of the
allografts
RCMV-infected and uninfected rat allografts collected at
2 and 8 weeks after transplantation were stained with
Masson’s trichrome stain to identify collagen deposits in
the media as described [38]. Collagen deposits were
assessed by computer-assisted histomorphometric image
analysis in Adobe Photoshop. To estimate collagen
content in the specimen, blue-stained areas were
selected and quantified by an image-analysis system.
The ranking procedure was performed in a blinded
approach by two observers who were unaware of the
coding.
Statistics and data analysis
The analysis was done on the cross sections of the allo-
grafts. The numbers of macrophages, lymphocytes,
SMCs and apoptotic SMCs among all intimal and med-
ial cells were determined by manual counting of cells
positive for CD68, CD45, CD3, SM-a actin and cells
double positive for caspase 3/SM-a-actin. RCMV-
infected macrophages were quantified by calculating the
percentage of cells double positive for late/early RCMV
R44 protein and CD68 among all CD68-positive cells.
MMP content was determined as the area immunos-
tained, expressed as a percentage of the total area.
Collagen deposits (blue-stained areas) and MCP-1 con-
tent (green-stained areas) were assessed by computer-
assisted histomorphometric image analysis in Adobe
Photoshop. All ranking procedures were performed in a
blinded approach by two observers who were unaware
of coding. Results in multiple groups were analyzed with
a two-tailed t-test, where the sample mean of the data
obtained from infected allografts was compared to unin-
fected ones (2 weeks infected vs. 2 weeks uninfected,
and 8 weeks infected vs. 8 weeks uninfected). P value
< 0.05 was considered as significant.
Results
RCMV infection of aortic allografts enhances intimal
hyperplasia and media destruction, and decreases
extracellular matrix deposition in the allograft
To examine how RCMV infection affects arterial remo-
deling and intimal hyperplasia, we measured the cross-
sectional area and circumference of the intima and media
in the tissue sections and counted the number of cell
nuclei counterstained with hematoxylin and cells of SM-
a-actin phenotype in both media and intima (Figure 1A).
We used the isograft control to confirm previous findings
that allogenic response is necessary to initiate graft remo-
deling [36,39]. Neither uninfected nor infected isograft
controls collected at 2 and 8 weeks post transplantation
developed intimal hyperplasia (Figure 1A). At 8 weeks,
the intimal cross-sectional area was threefold thicker in
infected allografts (p < 0.05) (Figure 1B) and contained
2.5-fold more cells (p < 0.05) compared to uninfected
allografts. Also the number of cells was increased in the
intima of RCMV-infected al l o g r a f t sa t8w e e k sa f t e r
transplantation compared to uninfected allografts at the
same time point. Our findings indicate that RCMV
increased intimal hyperplasia in the allografts and con-
tributed to vascular remodeling.
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infected grafts had fewer cells in the media (Figure 1B). To
further examine whether this loss of medial cells could be
attributed to an enhanced RCMV-induced apoptosis, we
double stained RCMV-infected- and uninfected allografts
for SM-a-actin and caspase 3 and found that apoptosis of
SMCs was significantly increased in the media of infected
allografts compared to uninfected controls both at
2 weeks (p < 0.001), and 8 weeks after transplantation (p <
0.05) (Figure 2).
To further assess the effects of RCMV infection on the
extracellular matrix (ECM) components, we examined col-
lagen deposition (Figure 3A). At 2 weeks post transplanta-
tion, similar amounts of collagen were present in infected
and uninfected allografts. At 8 weeks, RCMV-infected
allografts had less collagen (p < 0.05) (Figure 3A),
indicating that the virus directly or indirectly, affected col-
lagen turnover in the allografts. Therefore, we determined
the expression of two matrix metalloproteinases (MMPs)
that are major regulators of collagen turnover in the vessel
wall, MMP-2 and MMP-9 (Figure 3B and 3C). In infected
grafts, MMP-2 expression was confined to the adventitia
early after transplantation but was later detected in a dif-
fuse pattern in the whole vessel wall and was significantly
increased (p < 0.001) compared to uninfected allograft
(Figure 3B). MMP-9 expression was not affected by
RCMV infection (Figure 3C).
RCMV infection of aortic allografts induces widespread
inflammation in the intima and adventitia
Local RCMV infection resulted in a widespread inflamma-
tion of the intima and adventitia early after transplantation
Figure 1 RCMV infection of aortic allografts enhances intimal hyperplasia and contributes to vessel remodelling. (A) The figure presents
fragments of cross sections of RCMV-infected and uninfected allografts (controls) collected at 2 and 8 weeks after transplantation and stained for
SM-a-actin (SM-actin) (Columns 1 and 2). Columns 3 and 4 show fragments of cross sections of the RCMV-infected and uninfected isograft controls
at 2 and 8 weeks after transplantation to visualize that there was no intimal formation either in the infected or uninfected isografts. Blue, nuclei
counterstained with hematoxylin. Brown, cells positive for SM-a-actin. I, intima, M, media, A, adventitia. (B) Bar charts show areas of intima and
media presented as cross-sectional area (μm
2) (upper panels) and the number of cells per cross section in the intima and media (lower panels) in
RCMV-infected and uninfected allografts. At 2 weeks post transplantation the number of cells in the intima and media, and thickness of both layers
were similar in infected and uninfected allografts. At 8 weeks, the intima was 3-fold thicker in infected vs. uninfected allografts and contained 2.5-
fold more cells. The media of infected allografts had fewer cells at 8 week after transplantation. * p < 0.05 vs. control at 2 and 8 weeks, respectively.
Grudzinska et al. Herpesviridae 2010, 1:7
http://www.herpesviridae.org/content/1/1/7
Page 4 of 11(Figure 4A). To further characterize the phenotypes of
infiltrating cells in RCMV-infected rat aortic allografts,
we determined the presence of CD68-positive macro-
phages, CD45-positive leukocytes and CD3-positive
lymphocytes (Figure 4B, D, E). Interestingly, most of
the infiltrating cells were CD68-positive macrophages
(Figure 4B) and 80% of infiltrating macrophages were
RCMV-infected at 8 weeks post transplantation (Figure
4C). CD3-positive lymphocytes were only few and
mainly localized in the adventitia and subendothelial
area of the allografts at 2 weeks post transplantation
(Figure 4E). Moreover, infiltration of CD68-positive
macrophages into the intima was fourfold higher in
RCMV-infected allografts compared to uninfected con-
trols, both 2 weeks (p < 0.001) and 8 weeks (p < 0.01)
after transplantation (Figure 4F). In the media of
infected allografts the number of CD68-positive macro-
phages was twofold higher at 8 weeks compared to
uninfected controls (p <0 . 0 5 ) .I nt h ea d v e n t i t i a ,t h e r e
was a massive infiltration of CD68-positive macro-
phages, with a higher extent in the infected allografts.
We observed no significant effect of RCMV on infiltra-
tion of CD45-positive leukocytes to the allografts (Fig-
ure 4F). These findings indicate that RCMV induced a
strong inflammatory response consisting of mainly
CD68-positive macrophages in the allografts early and
late after transplantation, which likely influenced allo-
graft remodeling.
RCMV induces MCP-1 production in aortic allografts and
recruits cells from infected adventitia to the intima
Adventitial progenitor cells appear to be important in
vessel remodeling [40-43]. Recently, we found that
MCP-1 is a chemoattractant for vascular progenitor
cells in cardiac allografts and that their recruitment to
the allograft was increased by inflammation [11].
To further examine whether RCMV affected migration
of adventitial cells in the rat allograft we first examined
if MCP-1, which is a key chemokine responsible for
migration of vascular progenitor cells, was altered by
RCMV infection. At 2 weeks after transplantation,
R C M Vi n f e c t i o nr e s u l t e di nas e v e n f o l di n c r e a s ei nt h e
number of MCP-1 positive cells in the allografts (p <
0.001) and most of these cells were present in the
adventitia (Figure 5A). At 8 weeks, RCMV-infection
resulted in a 3.5-fold increase in the number of MCP-1
positive cells, which were present in all vascular layers
(p < 0.001) (Figure 5A).
To further examine if cells from RCMV-infected
adventitia migrated in vivo and thereby could contribute
to intimal hyperplasia, we transplanted infected fluores-
cently labeled isogenic adventitia to the aortic allografts
4 weeks after transplantation, the time point when inti-
mal hyperplasia is emerging [36]. At 2 weeks post
adventitia transplantation, we detected fluorescently
labeled cells in the intima (Figure 5B). Thus, RCMV
induced MCP-1 expression in vivo and induced migra-
tion of adventitial cells to the intima.
Discussion
CMV is thought to be a key pathogen involved in the
pathogenesis of TV in human allografts. To evaluate the
direct effect of CMV infection on vascular biology, we
used a rat model in which aortic allografts were infected
ex vivo with RCMV prior to transplantation. We chose
2 time points after transplantation to investigate the
development of TV, 2 weeks that represented the early
phase of TV in rats; and 8 weeks, when TV was fully
developed. We found that RCMV influenced vascular
remodeling by increased apoptosis of SM-a-actin
Figure 2 RCMV induces apoptosis of SMCs in the media layer
of the aortic allografts. Bar charts show the Apoptotic Index of
SMCs presented as the number of apoptotic SMCs per cross section
in media (A) and intima (B) of infected and uninfected allografts
(controls). Apoptotic SMCs were detected with double
immunostaining for SM-a-actin and caspase 3. Both at 2 and 8
weeks after transplantation there was a significant increase of
apoptotic SMCs in the media of infected allografts vs. uninfected
controls. *p < 0.05 vs. control at 8 weeks. ***p < 0.001 vs. control
at 2 weeks.
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matrix deposits and increased intimal hyperplasia. More-
over, RCMV induced a strong infiltration of CD68-posi-
tive macrophages mainly in the adventitia and resulted
in an increase of MCP-1 in the allograft, which resulted
in migration of adventitial cells towards the intima that
most likely also contributed to intimal hyperplasia.
Vessel stability is sustained by a balance between cel-
lular proliferation and apoptosis, and the synthesis or
degradation of extracellular matrix (ECM) components.
Alterations in this balance have been shown to contri-
bute to the development of vascular diseases. Previous
studies suggested that HCMV infection negatively
influenced coronary artery remodeling in the first year
after heart transplantation [12]. Moreover, systemic
RCMV infection stimulated arterial SMCs proliferation
when vascular injury was induced in the rat model
of restenosis [44], although in this particular study
the ECM content in the injured artery was not
determined.
Figure 3 RCMV increases expression of matrix metalloproteinases and decreases collagen deposition in the aortic allografts. (A) Cross
sections of RCMV-infected and uninfected allografts (controls) at 2 and 8 weeks post transplantation, stained with Masson’s trichrome to identify
collagen deposits. Blue, collagen; red, muscle fibers; black, nuclei; I, intima; M, media; A, adventitia. Bar chart shows the collagen deposits in the
allografts of RCMV-infected and uninfected allografts at 2 and 8 weeks post transplantation presented as the size (μm
2) of positive blue
immunostained area per cross section. *p < 0.05 vs. uninfected controls 8 weeks after transplantation. At 8 weeks, infected allografts had
significantly less collagen. (B) Cross sections of RCMV-infected and uninfected allografts (controls) stained to identify MMP-2. Brown indicates
positivity for MMP-2. I, intima; M, media; A, adventitia. Bar chart shows percentage of positive areas for MMP-2 in infected and uninfected allografts
at 2 and 8 weeks post transplantation determined as the percentage of positive area of the total cross section area. ***p < 0.001 vs. uninfected
controls at 8 weeks. (C) Cross sections of RCMV-infected and uninfected allografts (controls) stained to identify MMP-9. Brown indicates positivity for
MMP-9. I, intima; M, media; A, adventitia. Bar chart shows percentage of positive areas for MMP-9 in infected and uninfected allografts at 2 and 8
weeks post transplantation. Early after transplantation both MMP-2 and MMP-9 after confined mainly to the adventitia.
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infected allografts 2 and 8 weeks post transplantation stained to detect RCMV early/late antigen (R44-encoded protein). RCMV-infected cells
were localized mainly in the adventitia and intima of the allograft. Brown, cells positive for RCMV. I, intima; M, media; A, adventitia. (B) Cross
sections of RCMV-infected allografts and uninfected allografts (controls) at 2 and 8 weeks post transplantation stained for CD68-positive
macrophages. Brown indicates positive staining for CD68 that appears mainly in the intima and adventitia. I, intima; M, media; A, adventitia. (C)
Fragment of a cross section of RCMV-infected allograft double immunostained to detect RCMV-infected CD68-positive macrophages. 80% of
infiltrating CD68-positive macrophages were RCMV infected. Green, CD68-positive macrophages; blue, RCMV; red, nuclei. (D) Cross sections of
RCMV-infected allografts and uninfected controls at 2 and 8 weeks post transplantation stained for CD45-positive leukocytes. Brown indicates
positive staining for CD45 that appears mainly in the intima and adventitia. I, intima; M, media; A, adventitia. (E) Cross sections of RCMV-infected
allografts and uninfected controls at 2 and 8 weeks post transplantation stained for CD3-positive lymphocytes. Brown indicates positive staining
for CD3 that appears mainly in the adventitia. I, intima; M, media; A, adventitia. (F) Bar charts show a number of CD68- and CD45-positive
leukocytes in the media and intima of RCMV-infected and uninfected allografts (controls). Infiltration of CD68-positive macrophages into the
intima was 4-fold higher and 2-fold higher in the media of infected allografts compared to uninfected controls. At 8 weeks, there was a massive
infiltration of macrophages in the adventitia. ***p < 0.001 vs. uninfected control at 2 weeks in intima; **p < 0.01 vs. uninfected control at 8
weeks in intima; *p < 0.05 vs. uninfected control at 8 weeks in media.
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sis of SM-a-actin positive cells in the media, which con-
tributed to an earlier and enhanced destruction of the
medial layer after transplantation compared to unin-
fected allografts. This destruction of the media layer led
to further fibrosis and stimulation of intimal hyperplasia.
RCMV increased proliferation of SM-a-actin positive
cells in the intima resulting in intimal thickening in TV.
Consistent with other studies, we observed no intimal
formation in isogenic grafts (isografts) [22,36,45], even if
they were infected with CMV [27,31,35], which suggests
that allogenic response is necessary for CMV to further
trigger cellular responses in TV.
Collagen is the major component of the ECM in the
vessel wall and is crucial for vessel wall integrity. Here,
we found that RCMV decreased the collagen content in
the allografts late after transplantation. Moreover,
expression of MMP-2, which regulates collagen turnover
in the vessel wall and is thought to be altered in vascu-
lar diseases [46,47] was upregulated in infected allo-
grafts. These findings are in agreement with earlier
report showing that the expression of proteins involved
in MMP activation and ECM modification are induced
in RCMV-infected cardiac allografts as TV develops [5].
T h e s ef i n d i n g si n d i c a t et h a tR C M Vd i r e c t l yo rb y
interacting with host immunity reduces the integrity of
the artery wall and thereby increases tissue vulnerability
to injury, inflammation and uncontrolled remodeling.
Previous studies showed that RCMV induces an early
inflammatory response in the adventitia (perivasculitis)
and the subendothelial space [26] in a rat aortic trans-
plant model with systemic RCMV infection. However,
the types of infected cells in the graft were not identi-
fied. In murine models of cardiac transplantation,
mouse CMV infection resulted in chronic vascular rejec-
tion, intimal thickening, and vascular occlusion [48].
MCP-1 and its receptor (chemokine receptor 2) are
though to drive the recruitment of inflammatory cells
and cells with SM-a-actin phenotype to the sites of vas-
cular injury in atherosclerosis and TV [49]. MCP-1 tran-
scripts have been identified in RCMV-infected rat
cardiac allografts affected with TV [5]. Recently we
found that MCP-1 is a chemoattractant for progenitor
cells migrating to cardiac allografts, which was enhanced
by inflammation [11]. We also showed that antibodies to
MCP-1 significantly reduced inflammation and accumu-
lation of these cells in the graft.
In our study, we observed RCMV-dependent recruit-
ment of CD68-positive macrophages. The infiltration of
lymphocytes into the allograft was mainly confined to
Figure 5 RCMV increases expression of MCP-1 in the aortic allografts and cells from the infected adventitia migrate towards the
intima. (A) Cross sections of the RCMV-infected and uninfected allografts (controls) at 2 and 8 weeks post transplantation stained for MCP-1.
Green, MCP-1. Bar chart shows MCP-1 expression in the allografts, presented as positive area of the cross section (μm
2). Both at 2 and 8 weeks
after transplantation MCP-1 expression was increased in infected allografts (7-fold at 2 weeks and 3.5-fold at 8 weeks post transplantation).
***p < 0.001 vs. uninfected control at 2 and 8 weeks, respectively. I, intima; M, media; A, adventitia. (B) Cross section of the aortic allograft with
transplanted fluorescently labeled isogenic adventitial graft. Grafts were collected 2 weeks post adventitia transplantation. Picture shows labeled
blue adventitial cells in the allograft intima. Green, SM-actin; Blue, migrated adventitial cells; Red, nuclei.
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transplantation. This pattern was also previously
observed by us and other authors in the similar
animal models of TV [36,39], as well as in the models
of RCMV-infected rat aortic and cardiac allografts
[26,50,51]. The lymphocytic infiltration was observed
until 1 week post transplantation [26] but not thereafter
and late inflammatory response consisted mainly of
macrophages.
We also observed that MCP-1 is highly expressed in
infected allografts in areas of the artery with high num-
bers of macrophages. This scenario may contribute to
the pro-inflammatory state in the allograft, resulting in
release of inflammatory cytokines and chemokines that
accelerate the inflammatory process and sustain further
viral replication [21] and vascular remodeling. Impor-
tantly, CMV also carries chemokines and chemokine
receptor homologues that recruit and stimulate cellular
infiltration, and thereby further potentiate the inflamma-
tory response [52]. Furthermore, several studies have
shown that infection with viruses can result in the up-
regulation of the eicosanoid pathways [53,54]. A rela-
tionship between CMV and enhanced cyclooxygenase-2
(COX-2) expression has been identified both in vitro
and in vivo [55,56]. COX-2 and prostaglandin pathways
are up-regulated in CMV infected cells and this may be
essential for efficient CMV replication [55]. Interestingly,
in the CMV-infected SMCs, induced 5-Lipoxygenase
expression and increased leukotriene B4 production may
promote inflammation through induced infiltration and
activation of leukocytes [17,57]. Thus, CMV infection of
tissues may exacerbate inflammation and contribute to
the observed pathology.
The vascular adventitia has been implied as a source
of cells that contribute to intimal hyperplasia [41,43,58]
and migrate in the vessel wall in order to localize in vas-
cular lesions [59]. Here, we investigated whether cells
derived from infected adventitia migrated to the intima
and if migration of adventitial cells was altered by
RCMV. We transplanted fluorescently labeled RCMV-
infected adventitia to the allografts 4 weeks after the
allograft transplantation and found that adventitial cells
migrated to the intima and most likely contributed to
intimal hyperplasia. Interestingly, we showed that
RCMV infection significantly enhanced MCP-1 produc-
tion in the allograft and thereby created the environ-
ment to support cellular migration. Our observation is
consistent with our previous finding that expression of
the virally encoded chemokine receptor chomologue,
US28 in the presence of CC chemokines, including
MCP-1, was sufficient to promote cellular migration
[21]. Moreover, it suggests that the virus itself creates
pro-inflammatory environment and is able to alter cellu-
lar processes involved in the development of TV.
Conclusions
In summary, acute RCMV infection of allografts led to
enhanced MCP-1 production and massive infiltration of
macrophages, following transplantation, resulting in
inflammation and vascular remodeling that contributed
to more rapid and severe vessel narrowing. Our findings
increase understanding of the CMV role in vessel remo-
deling and highlight the importance of managing CMV
infections in transplant patients.
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